Table 2.
Characteristics of Helicobacter pylori persistent infection and successful eradication group
| Total (n = 142) | Infection (n = 89) | Eradication (n = 53) | P |
|---|---|---|---|
| Mean age (range), y | 64.1 (30‐89) | 64.9 (37‐84) | .6942 |
| Sex, n (%) | |||
| Female | 40 (44.9%) | 21 (63.6%) | .5355 |
| Male | 49 (55.1%) | 32 (36.4%) | |
| Mean BMI (range), kg/m2 | 22.3 (17.8‐32.1) | 22.7 (15.9‐32.4) | .4060 |
| Past history of cancer, yes | 12 (13.5%) | 11 (20.8%) | .2553 |
| Family history of gastric cancer, yes | 21 (23.6%) | 18 (34.0%) | .1806 |
| Smoking | |||
| None | 57 (64.0%) | 37 (69.8%) | .2560 |
| Brinkman Index <400 | 8 (8.99%) | 8 (15.1%) | |
| Brinkman Index ≥400 | 20 (22.5%) | 7 (13.2%) | |
| Alcohol | |||
| None | 30 (33.7%) | 21 (39.6%) | .6695 |
| <20 g/d | 26 (29.2%) | 17 (32.1%) | |
| ≥20 g/d | 29 (32.6%) | 14 (26.4%) | |
| Endoscopy within 2 y | 12 (13.5%) | 42 (79.2%) | <.0001a |
| Atrophic gastritis | |||
| C‐1 | 0 | 0 | .0599 |
| C‐2 | 5 (5.62%) | 9 (17.0%) | |
| C‐3 | 4 (4.49%) | 4 (7.55%) | |
| O‐1 | 8 (8.99%) | 9 (17.0%) | |
| O‐2 | 18 (20.2%) | 8 (15.1%) | |
| O‐3 | 54 (60.7%) | 23 (43.4%) | |
| Stage, n (%) | |||
| I | 68 (76.4%) | 50 (94.3%) | .0251a |
| II | 10 (11.2%) | 3 (5.66%) | |
| III | 5 (5.62%) | 0 | |
| IV | 6 (6.74%) | 0 | |
| Location | |||
| Upper third | 21 (23.6%) | 5 (9.43%) | .0761 |
| Middle third | 33 (37.1%) | 27 (50.9%) | |
| Lower third | 35 (39.3%) | 21 (39.6%) | |
| Mean size (range), mm | 38.3 (3.0‐180) | 16.9 (1.0‐100) | <.0001a |
| Pathology | |||
| Intestinal type | 56 (62.9%) | 46 (86.8%) | .0022a |
| Diffuse type | 33 (37.1%) | 7 (13.2%) | |
| Treatment for gastric cancer | |||
| Endoscopy | 38 (42.7%) | 39 (73.6%) | .0022a |
| Surgery | 42 (47.2%) | 13 (24.5%) | |
| Chemotherapy | 5 (5.62%) | 0 | |
| Best supportive care | 2 (2.25%) | 0 | |
| Observation | 2 (2.25%) | 1 (1.89%) | |
BMI, body mass index.
a
Statistically significant.